跳至主要内容
临床试验/NCT01753349
NCT01753349已完成不适用

An International Observational Prospective Study On Long-Term Response To Botulinum Toxin Type A (BoNT-A) Injections In Subjects Suffering From Idiopathic Cervical Dystonia (CD) - Pharmaco-Economic Impact

Ipsen113 个研究点 分布在 14 个国家目标入组 1,050 人开始时间: 2012年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Ipsen
入组人数
1,050
试验地点
113
主要终点
Change in subject's satisfaction using a 5-point Likert scale.

研究概览

简要总结

The purpose of the study is to document long-term response in real-life practice after injection cycles with BoNT-A in subjects suffering from idiopathic cervical dystonia (Long-term clinical and pharmaco-economic data).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject for whom there is an intention to treat with BoNT-A.
  • BoNT treatment naïve or previously treated with BoNT.
  • If previously treated with BoNT, at least a 12-week interval between the last injection (BoNT-A or BoNT-B) and inclusion.
  • Subject able to comply with the protocol.
  • Provision of written informed consent prior to collect the data.

排除标准

  • Contraindications to any BoNT-A preparations.
  • The subject has already been included in the study.

结局指标

主要结局

Change in subject's satisfaction using a 5-point Likert scale.

时间窗: Baseline and at every 3 to 4 months, up to 3 years.

Identification of prognostic factors for subject's satisfaction regarding control of symptoms associated with idiopathic CD.

次要结局

  • Change in tremor associated with CD using Tsui score(Baseline and at every 3 to 4 months, up to 3 years.)
  • Change in disability will be measured with the TWSTRS disability sub-scale.(Baseline and at every 3 to 4 months, up to 3 years.)
  • Change from baseline in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) total score and severity sub-scale.(Baseline and at every 3 to 4 months, up to 3 years.)
  • Change in pain relief assessed using the TWSTRS pain sub-scale.(Baseline and at every 3 to 4 months, up to 3 years.)
  • Pharmaco-economic endpoints(Baseline and at every 3 to 4 months, up to 3 years.)

研究者

发起方
Ipsen
申办方类型
Industry
责任方
Sponsor

研究点 (113)

Loading locations...

相似试验

Phase IV-Cervical Dystonia-INTEREST IN CD2 | 临床试验